Trilogy Capital Inc. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Trilogy Capital Inc. acquired a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,225 shares of the medical research company’s stock, valued at approximately $2,748,000. Several other large investors have […]

Leave a Reply

Your email address will not be published.

Previous post What are the Chicago Cubs’ NL Central chances in 2024? A youth infusion in the division means a title won’t come easily.
Next post Bard Financial Services Inc. Buys 125 Shares of Caterpillar Inc. (NYSE:CAT)